Ireland
--:--IST
Updated daily · official EMA data

EMA Drug Approvals Tracker

Every EU marketing authorisation from the last 12 months - new medicines, biosimilars and generics approved centrally through the European Medicines Agency - plus CHMP positive opinions still awaiting a European Commission decision.

75
Authorisations · 12 months
54
New medicines
16
Orphan medicines
26
Awaiting EC decision

Latest EU marketing authorisations

AuthorisedMedicineTypeMarketing Authorisation Holder
12 Nov 2026 Zeydovio
glepaglutide · Various alimentary tract and metabolism products
2 clinical trials →
New Medicine Zealand Pharma A/S
12 Nov 2026 Sepalna
senaparib · Antineoplastic agents
2 clinical trials →
New Medicine
12 Nov 2026 Inijaq
tofacitinib · Immunosuppressants
28 clinical trials →
Generic Gedeon Richter Plc.
12 Nov 2026 Povofortay
povorcitinib · Immunosuppressants
8 clinical trials →
New Medicine Incyte Biosciences Distribution B.V.
12 Nov 2026 Ruxolitinib Zentiva
ruxolitinib · Antineoplastic agents
71 clinical trials →
Generic Zentiva k.s.
22 Oct 2026 Lynavoy
Linerixibat · Bile and liver therapy
New MedicineOrphan GlaxoSmithKline Trading Services Limited
25 Sep 2026 Cavoley
pegfilgrastim · Immunostimulants
17 clinical trials →
Biosimilar CuraTeQ Biologics s.r.o
21 Sep 2026 Nezglyal
leriglitazone · Other alimentary tract and metabolism products
New MedicineOrphan Minoryx Therapeutics S.L.
18 Sep 2026 Tafamidis Accord
tafamidis · Other nervous system drugs
Generic Accord Healthcare S.L.U.
18 Sep 2026 Ruxolitinib Viatris
ruxolitinib hemifumarate · Antineoplastic agents
Generic Viatris Limited
18 Sep 2026 Susvimo
ranibizumab · Ophthalmologicals
14 clinical trials →
New Medicine Roche Registration GmbH
18 Sep 2026 Icotyde
icotrokinra hydrochloride · Immunosuppressants
10 clinical trials →
New Medicine Janssen-Cilag International
18 Sep 2026 Zokovea
ensitrelvir · Antivirals for systemic use
New Medicine Shionogi B.V.
28 Aug 2026 Denosumab Ascend
denosumab
24 clinical trials →
Biosimilar Ascend GmbH
20 Aug 2026 Hopledo
levodopa;carbidopa · Anti-Parkinson drugs
2 clinical trials →
New Medicine Zambon SpA
20 Aug 2026 Daybu
trofinetide · Other nervous system drugs
New MedicineOrphan Acadia Pharmaceuticals B.V.
20 Aug 2026 Aujemflu
Influenza vaccine (surface antigen, inactivated, adjuvanted, prepared in cell culture) · Vaccines
New Medicine Seqirus Netherlands B.V.
24 Jul 2026 Colchicine Agepha Pharma
colchicine · Antigout preparations
47 clinical trials →
New Medicine Agepha Pharma s.r.o.
20 Jul 2026 Etcamah
camizestrant · Endocrine therapy
13 clinical trials →
New Medicine AstraZeneca AB
15 Jul 2026 Jascayd
nerandomilast · Immunosuppressants
7 clinical trials →
New Medicine Boehringer Ingelheim International GmbH
15 Jul 2026 Liraglutide STADA
liraglutide · Drugs used in diabetes
7 clinical trials →
New Medicine STADA Arzneimittel AG
15 Jul 2026 Ablymico
liraglutide · Drugs used in diabetes
7 clinical trials →
New Medicine STADA Arzneimittel AG
15 Jul 2026 Vislyfa
ranibizumab · Ophthalmologicals
14 clinical trials →
Biosimilar Lupin Europe GmbH
15 Jul 2026 Vijoice
alpelisib · Antineoplastic agents
22 clinical trials →
New MedicineOrphan Novartis Europharm Limited
15 Jul 2026 Boey
trenibotulinumtoxinE · MUSCLE RELAXANTS;Other muscle relaxants, peripherally acting agents
New Medicine AbbVie Limited
30 Jun 2026 Itvisma
onasemnogene abeparvovec · Other drugs for disorders of the musculo-skeletal system
New Medicine Novartis Europharm Limited
19 Jun 2026 Palbociclib Viatris
palbociclib · Antineoplastic agents
78 clinical trials →
Generic Viatris Limited
19 Jun 2026 Cenrifki
tolebrutinib · Selective immunosuppressants
New Medicine Sanofi Winthrop Industrie
19 Jun 2026 Rexatilux
ranibizumab · Ophthalmologicals
14 clinical trials →
Biosimilar Intas Third Party Sales 2005 S.L.
19 Jun 2026 Redemplo
plozasiran · Lipid modifying agents
2 clinical trials →
New MedicineOrphan Arrowhead Pharmaceuticals Ireland Limited
29 May 2026 Bopediat
furosemide · Sulfonamides, plain;Diuretics
15 clinical trials →
New Medicine Proveca Pharma Limited
29 May 2026 Imdylltra
tarlatamab · Antineoplastic agents
27 clinical trials →
New MedicineOrphan Amgen Europe B.V.
29 May 2026 Zepzelca
lurbinectedin · Antineoplastic agents
17 clinical trials →
New MedicineOrphan Pharma Mar S.A.
28 May 2026 Adstiladrin
nadofaragene firadenovec · Antineoplastic agents
3 clinical trials →
New MedicineATMP Ferring Pharmaceuticals A/S
21 May 2026 Joenja
leniolisib · Antineoplastic agents
3 clinical trials →
New MedicineOrphan Pharming Technologies B.V.
06 May 2026 Bysumlog
insulin lispro · Drugs used in diabetes
Biosimilar Sandoz GmbH
27 Apr 2026 Dazparda
insulin aspart · Drugs used in diabetes
4 clinical trials →
Biosimilar Sandoz GmbH
27 Apr 2026 Onerji
levodopa;carbidopa · Anti-Parkinson drugs
2 clinical trials →
New Medicine Tanabe Pharma GmbH
27 Apr 2026 Xolremdi
mavorixafor · Immunostimulants
New MedicineOrphan Norgine B.V.
27 Apr 2026 Tuyory
tocilizumab · Immunosuppressants
75 clinical trials →
Biosimilar Chemical Works of Gedeon Richter Plc. (Gedeon Richter Plc.)
27 Apr 2026 Zandoriah
teriparatide · Calcium homeostasis
5 clinical trials →
Biosimilar CinnaGen Co Unipessoal LDA
23 Apr 2026 Poherdy
pertuzumab · Antineoplastic agents
92 clinical trials →
Biosimilar Organon N.V.
23 Apr 2026 Palsonify
paltusotine · Pituitary and hypothalamic hormones and analogues
New MedicineOrphan Crinetics Pharmaceuticals Europe GmbH
23 Apr 2026 Fubelv
etanercept · etanercept
11 clinical trials →
Biosimilar Biosimilar Collaborations Ireland Limited
23 Apr 2026 Rhapsido
remibrutinib · Immunosuppressants
21 clinical trials →
New Medicine Novartis Europharm Limited
20 Apr 2026 mCombriax
influenza mRNA vaccine;COVID-19 mRNA vaccine · Vaccines
New Medicine Moderna Biotech Spain, S.L.
20 Apr 2026 Ojemda
tovorafenib · Antineoplastic agents
6 clinical trials →
New MedicineOrphan Ipsen Pharma
15 Apr 2026 Enflonsia
clesrovimab · Immune sera and immunoglobulins
New Medicine Merck Sharp Dohme Limited
30 Mar 2026 Supemtek
trivalent influenza vaccine (recombinant, prepared in cell culture) · Vaccines
New Medicine Sanofi Winthrop Industrie
26 Mar 2026 Kygevvi
doxecitine;doxribtimine · Other alimentary tract and metabolism products
New MedicineOrphanPRIME UCB Pharma
26 Mar 2026 Kayshild
semaglutide · Drugs used in diabetes
137 clinical trials →
New Medicine Novo Nordisk A/S
26 Mar 2026 Fylrevy
estetrol · Sex hormones and modulators of the genital system
New Medicine Gedeon Richter Plc.
26 Mar 2026 Ilumira
lutetium (177Lu) chloride · Therapeutic radiopharmaceuticals
New Medicine Shine Europe B.V.
24 Mar 2026 Rezurock
belumosudil · Immunosuppressants
7 clinical trials →
New MedicineOrphan Sanofi Winthrop Industrie
16 Feb 2026 Anktiva
nogapendekin alfa inbakicept · Immunostimulants
New Medicine Immunitybio Ireland Limited
12 Feb 2026 mNexspike
COVID-19 mRNA vaccine · Vaccines
New Medicine Moderna Biotech Spain, S.L.
12 Feb 2026 Myqorzo
aficamten
3 clinical trials →
New Medicine Cytokinetics (Ireland) Limited
12 Feb 2026 Exdensur
depemokimab · Drugs for obstructive airway diseases
9 clinical trials →
New Medicine GlaxoSmithKline Trading Services Limited
10 Feb 2026 Gotenfia
golimumab · Immunosuppressants
6 clinical trials →
Biosimilar Stada Arzneimittel AG
10 Feb 2026 Ranluspec
ranibizumab · Ophthalmologicals
14 clinical trials →
Biosimilar Lupin Europe GmbH
19 Jan 2026 Aqneursa
L-acetylleucine · Other nervous system drugs
New MedicineOrphan Intrabio Ireland Limited
19 Jan 2026 Dawnzera
donidalorsen · Other hematological agents
2 clinical trials →
New Medicine Otsuka Pharmaceutical Netherlands B.V.
09 Jan 2026 Ondibta
insulin glargine · Drugs used in diabetes
5 clinical trials →
Biosimilar Sandoz GmbH
09 Jan 2026 Waskyra
etuvetidigene autotemcel · Other hematological agents
New MedicineOrphanATMP Fondazione Telethon ETS
09 Jan 2026 VacPertagen
pertussis vaccine (recombinant, acellular, component, adsorbed) · Vaccines
New Medicine BioNet Europe
09 Jan 2026 Inluriyo
imlunestrant · Endocrine therapy
10 clinical trials →
New Medicine Eli Lilly Nederland B.V.
08 Jan 2026 Teduglutide Viatris
teduglutide · Other alimentary tract and metabolism products
2 clinical trials →
Generic Viatris Limited
08 Jan 2026 Teizeild
teplizumab · Drugs used in diabetes
7 clinical trials →
New MedicinePRIME Sanofi Winthrop Industrie
08 Jan 2026 Osqay
denosumab · Drugs for treatment of bone diseases
24 clinical trials →
Biosimilar Theramex Ireland Limited
08 Jan 2026 Austedo
deutetrabenazine · Other nervous system drugs
New Medicine Teva GmbH
08 Jan 2026 GalenVita
germanium (68Ge) chloride;gallium (68Ga) chloride · Diagnostic radiopharmaceuticals
New Medicine Curium Romania S.R.L.
22 Dec 2025 Wayrilz
rilzabrutinib · Not assigned yet
10 clinical trials →
New MedicineOrphan Sanofi B.V.
28 Nov 2025 Imaavy
nipocalimab · Immunosuppressants
11 clinical trials →
New Medicine Janssen Cilag International NV
24 Nov 2025 Kyinsu
insulin icodec;semaglutide · Insulins and analogues for injection, long-acting
9 clinical trials →
New Medicine Novo Nordisk A/S
21 Nov 2025 Svariya (previously Rivaroxaban Koanaa)
rivaroxaban · Antithrombotic agents
51 clinical trials →
Generic PGF Pharma International d.o.o.

CHMP positive opinions awaiting EC decision

OpinionMedicineTypeApplicant
12 Nov 2026 Aumseqa
Aumolertinib
New Medicine SFL Pharmaceuticals Deutschland GmbH
12 Nov 2026 Baxfendy
baxdrostat
3 clinical trials →
New Medicine AstraZeneca AB
12 Nov 2026 Donrafylix
insulin aspart
4 clinical trials →
Biosimilar Kuraci
12 Nov 2026 Fondaparinux sodium Evumed
fondaparinux sodium
Generic Evumed Limited
12 Nov 2026 Garzulys
insulin aspart
4 clinical trials →
Biosimilar Sciencepharma Sp. z o.o
12 Nov 2026 Ruxolitinib Krka
ruxolitinib
71 clinical trials →
Generic KRKA tovarna zdravil d.d. Novo mesto
12 Nov 2026 Zybrivo
sintilimab
208 clinical trials →
New Medicine Fortvita Biologics (Ireland) Limited
15 Oct 2026 Fovlussea
ranibizumab
14 clinical trials →
Biosimilar Accord Healthcare S.L.U.
15 Oct 2026 Neuzafy
filgrastim
17 clinical trials →
Biosimilar CuraTeQ Biologics (Malta) Limited
15 Oct 2026 Foundayo
Orforglipron
18 clinical trials →
New Medicine Eli Lilly Nederland B.V.
15 Oct 2026 Kizfizo
temozolomide
107 clinical trials →
New MedicineOrphan ORPHELIA Pharma
15 Oct 2026 Yuviwel
Navepegritide
2 clinical trials →
New MedicineOrphan Ascendis Pharma Growth Disorders A/S
15 Oct 2026 Rasonque
Daraxonrasib
New MedicineOrphan Revolution Medicines Netherlands B.V.
17 Sep 2026 Adcomfo
omalizumab
12 clinical trials →
Biosimilar Advanz Pharma Limited
17 Sep 2026 Frehemgo
denecimig
New Medicine Novo Nordisk A/S
17 Sep 2026 Lifyorli
relacorilant
5 clinical trials →
New MedicineOrphan Corcept Therapeutics Netherlands B.V.
17 Sep 2026 Gevalka
ensartinib
11 clinical trials →
New Medicine SFL Pharmaceuticals Deutschland GmbH
17 Sep 2026 Klygefa
gefurulimab
New Medicine Alexion Europe
17 Sep 2026 VaxRabeo
rabies vaccine (inactivated) for human
New Medicine Sanofi Winthrop Industrie
23 Jul 2026 Evlarco
obicetrapib;ezetimibe
6 clinical trials →
New Medicine A. Menarini International Licensing S.A.
23 Jul 2026 Lyrokaul
lerodalcibep
4 clinical trials →
New Medicine LIB Therapeutics B.V.
23 Jul 2026 Ubeslo
obicetrapib
6 clinical trials →
New Medicine A. Menarini International Licensing S.A.
23 Jul 2026 Riociguat Accord
riociguat
2 clinical trials →
Generic Accord Healthcare S.L.U.
25 Jun 2026 Nylaspeg
pegfilgrastim
17 clinical trials →
Biosimilar Qilu Pharma Spain S.L.
25 Jun 2026 Onswik
Insulin efsitora alfa
New Medicine Eli Lilly Nederland B.V.
30 Jan 2025 Skojoy
aflibercept
43 clinical trials →
Biosimilar Amgen Technology (Ireland) UC

A CHMP positive opinion is the scientific recommendation of the EMA's Committee for Medicinal Products for Human Use. The European Commission normally issues the legally binding marketing authorisation within 67 days of the opinion.

Source: European Medicines Agency medicines data - centrally authorised human medicines only; nationally authorised products are not included. Compare the US market in our FDA Approvals Tracker and FDA Recall Tracker, see the EU Clinical Trials Tracker for the trials behind these approvals, or cross-reference the Irish market in the Irish Medicines Database.